Boström E, Bachhav SS, Xiong H, Zadikoff C, Li Q, Cohen E, Dreher I, Torrång A, Osswald G, Moge M, Appelkvist P, Fälting J, Odergren T. Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti-α-Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults. J Clin Pharmacol. 2024 Aug 6; PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Exidavnemab